ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q4 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $235,000 | -65.2% | 2,002 | -60.1% | 0.01% | -66.7% |
| Q4 2021 | $675,000 | -69.4% | 5,019 | -70.1% | 0.02% | -69.4% |
| Q2 2021 | $2,209,000 | +145.4% | 16,793 | +140.4% | 0.05% | +145.0% |
| Q1 2021 | $900,000 | -10.4% | 6,984 | +16.1% | 0.02% | +5.3% |
| Q4 2020 | $1,004,000 | -36.0% | 6,018 | -40.8% | 0.02% | -54.8% |
| Q3 2020 | $1,568,000 | +5.5% | 10,163 | +1.1% | 0.04% | -2.3% |
| Q2 2020 | $1,486,000 | +174.2% | 10,049 | +108.7% | 0.04% | +104.8% |
| Q1 2020 | $542,000 | -22.1% | 4,815 | -3.7% | 0.02% | +90.9% |
| Q4 2019 | $696,000 | +82.2% | 5,000 | -77.3% | 0.01% | -35.3% |
| Q1 2015 | $382,000 | – | 22,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
| Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
| Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
| Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
| Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
| Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
| Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
| Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
| Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
| Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |